Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Cancer Invest. 1997;15(5):491-9.

    Immunogenicity of membrane-bound gangliosides in viable whole-cell vaccines.

    Source

    Laboratory of Glycolipid Immunotherapy, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, California 90404, USA.

    PMID:
    9316631
    [PubMed - indexed for MEDLINE]

    LinkOut - more resources

    Full Text Sources

    Other Literature Sources

      Supplemental Content

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk